BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 9062351)

  • 1. A potential role for interleukin-15 in the regulation of human natural killer cell survival.
    Carson WE; Fehniger TA; Haldar S; Eckhert K; Lindemann MJ; Lai CF; Croce CM; Baumann H; Caligiuri MA
    J Clin Invest; 1997 Mar; 99(5):937-43. PubMed ID: 9062351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukins 2 and 15 regulate Ets1 expression via ERK1/2 and MNK1 in human natural killer cells.
    Grund EM; Spyropoulos DD; Watson DK; Muise-Helmericks RC
    J Biol Chem; 2005 Feb; 280(6):4772-8. PubMed ID: 15563472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines.
    Bluman EM; Bartynski KJ; Avalos BR; Caligiuri MA
    J Clin Invest; 1996 Jun; 97(12):2722-7. PubMed ID: 8675682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
    Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA
    J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.
    Levitt LJ; Nagler A; Lee F; Abrams J; Shatsky M; Thompson D
    J Clin Invest; 1991 Jul; 88(1):67-75. PubMed ID: 1676038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells.
    Leclercq G; Debacker V; de Smedt M; Plum J
    J Exp Med; 1996 Aug; 184(2):325-36. PubMed ID: 8760786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.
    Carson WE; Giri JG; Lindemann MJ; Linett ML; Ahdieh M; Paxton R; Anderson D; Eisenmann J; Grabstein K; Caligiuri MA
    J Exp Med; 1994 Oct; 180(4):1395-403. PubMed ID: 7523571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of interleukin-12- and interleukin-15-induced natural killer cell activation by interleukin-4.
    Salvucci O; Mami-Chouaib F; Moreau JL; Thèze J; Chehimi J; Chouaib S
    Eur J Immunol; 1996 Nov; 26(11):2736-41. PubMed ID: 8921963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells.
    Azzoni L; Zatsepina O; Abebe B; Bennett IM; Kanakaraj P; Perussia B
    J Immunol; 1998 Oct; 161(7):3493-500. PubMed ID: 9759869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Il-2-induced adherence of human natural killer cells. Expression of mRNA for cytokines and IL-2 receptors in adherent NK cells.
    Vitolo D; Vujanovic NL; Rabinowich H; Schlesinger M; Herberman RB; Whiteside TL
    J Immunol; 1993 Aug; 151(4):1926-37. PubMed ID: 8345189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro.
    Carson WE; Ross ME; Baiocchi RA; Marien MJ; Boiani N; Grabstein K; Caligiuri MA
    J Clin Invest; 1995 Dec; 96(6):2578-82. PubMed ID: 8675621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine requirements for the growth and development of mouse NK cells in vitro.
    Toomey JA; Gays F; Foster D; Brooks CG
    J Leukoc Biol; 2003 Aug; 74(2):233-42. PubMed ID: 12885940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The functional characterization of interleukin-10 receptor expression on human natural killer cells.
    Carson WE; Lindemann MJ; Baiocchi R; Linett M; Tan JC; Chou CC; Narula S; Caligiuri MA
    Blood; 1995 Jun; 85(12):3577-85. PubMed ID: 7540068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin (IL)-2 and IL-15 have different effects on human natural killer lymphocytes.
    Pillet AH; Thèze J; Rose T
    Hum Immunol; 2011 Nov; 72(11):1013-7. PubMed ID: 21925225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.
    Lauwerys BR; Renauld JC; Houssiau FA
    Cytokine; 1999 Nov; 11(11):822-30. PubMed ID: 10547269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-alpha regulates IL-21 and IL-21R expression in human NK and T cells.
    Strengell M; Julkunen I; Matikainen S
    J Leukoc Biol; 2004 Aug; 76(2):416-22. PubMed ID: 15178704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cells express novel functional IL-15 receptor alpha isoforms.
    Bulanova E; Budagian V; Orinska Z; Krause H; Paus R; Bulfone-Paus S
    J Immunol; 2003 May; 170(10):5045-55. PubMed ID: 12734349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice.
    Koka R; Burkett PR; Chien M; Chai S; Chan F; Lodolce JP; Boone DL; Ma A
    J Exp Med; 2003 Apr; 197(8):977-84. PubMed ID: 12695489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 x IL-15R alpha fusion proteins.
    Mortier E; Quéméner A; Vusio P; Lorenzen I; Boublik Y; Grötzinger J; Plet A; Jacques Y
    J Biol Chem; 2006 Jan; 281(3):1612-9. PubMed ID: 16284400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface and intracellular interleukin-2 receptor expression on various resting and activated populations involved in cell-mediated immunity in human peripheral blood.
    Hodge S; Hodge G; Flower R; Han P
    Scand J Immunol; 2000 Jan; 51(1):67-72. PubMed ID: 10632978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.